Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Pulmonology

Clinical Pharmacology

Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy

Lung Cancer | Mar 15, 2018 Clinical Pharmacology

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016

BMC Cancer | Mar 14, 2018 Clinical Pharmacology

Refractory airway type-2 inflammation in a large subgroup of asthmatics treated with inhaled corticosteroids

The Journal of Allergy and Clinical Immunology | Mar 13, 2018 Clinical Pharmacology

Association of immune-related adverse events with nivolumab efficacy in non–small-cell lung cancer

JAMA Oncology | Mar 12, 2018 Clinical Pharmacology

Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations

New England Journal of Medicine | Mar 10, 2018 Clinical Pharmacology

Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study

Respiratory Medicine | Mar 09, 2018 Clinical Pharmacology

Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial

Allergy and Asthma Proceedings | Mar 09, 2018 Clinical Pharmacology

A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer

Journal for ImmunoTherapy of Cancer | Mar 09, 2018 Clinical Pharmacology

Randomized trial to assess the efficacy and safety of beclomethasone dipropionate breath-actuated inhaler in patients with asthma

Allergy and Asthma Proceedings | Mar 08, 2018 Clinical Pharmacology

Asthma control, lung function, symptoms, and corticosteroid sparing after omalizumab initiation in patients with allergic asthma

Allergy and Asthma Proceedings | Mar 07, 2018 Clinical Pharmacology

« Prev 1 … 62 63 64 65 66 … 80 Next »

Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016

Refractory airway type-2 inflammation in a large subgroup of asthmatics treated with inhaled corticosteroids

Association of immune-related adverse events with nivolumab efficacy in non–small-cell lung cancer

Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations

Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study

Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial

A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer

Randomized trial to assess the efficacy and safety of beclomethasone dipropionate breath-actuated inhaler in patients with asthma

Asthma control, lung function, symptoms, and corticosteroid sparing after omalizumab initiation in patients with allergic asthma

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

The Role of Nutrition in Enhancing Fertility for Men and Women

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

More Women Experience Chronic Pain Than Men: Find Out Why

Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016

Refractory airway type-2 inflammation in a large subgroup of asthmatics treated with inhaled corticosteroids

Association of immune-related adverse events with nivolumab efficacy in non–small-cell lung cancer

Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations

Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study

Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial

A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer

Randomized trial to assess the efficacy and safety of beclomethasone dipropionate breath-actuated inhaler in patients with asthma

Asthma control, lung function, symptoms, and corticosteroid sparing after omalizumab initiation in patients with allergic asthma

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

The Role of Nutrition in Enhancing Fertility for Men and Women

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

More Women Experience Chronic Pain Than Men: Find Out Why

Select Specialty

Select Topic